Crystalline Forms of Therapeutic Compounds and Uses Thereof (2017)
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,253,036 | Crystalline Forms of Therapeutic Compounds and Uses Thereof In force · High confidence | Kala Bio, Inc. | In force | High confidence | ||
| US 11,021,487 | Crystalline Forms of Therapeutic Compounds and Uses Thereof Lapsed Jun 1, 2025 on the fee record Ended Jun 1, 2025 · High confidence | Kala Bio, Inc. | Lapsed Jun 1, 2025 on the fee record | Ended Jun 1, 2025 | High confidence | |
| Application 17/315,080 | Crystalline Forms of Therapeutic Compounds and Uses Thereof Abandoned Abandoned Oct 17, 2023 | Kala Bio, Inc. | Abandoned | Abandoned Oct 17, 2023 |
3 of 3 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Kala Bio, Inc..
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.